Brief: Tenaya Therapeutics Reports First Quarter 2022 Results
11/05/2022 22:54
May 11 (Reuters) - Tenaya Therapeutics Inc TNYA.O :
* TENAYA THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* Q1 LOSS PER SHARE $0.75
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.75
* TENAYA THERAPEUTICS - EXPECTS CURRENT CASH, CASH
EQUIVALENTS,
INVESTMENTS IN MARKETABLE SECURITIES SUFFICIENT TO FUND
OPERATING PLAN INTO H2 2023
* Q1 EARNINGS PER SHARE VIEW $-0.65 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw3gSGLYa
Further company coverage: TNYA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tenaya Therapeutics
See all newsBrief: Tenaya Therapeutics Announces Interim Data From Mypeak™-1 Showing Treatment Of Mybpc3-Associated Hcm With TN-201 Gene Therapy Resulted In Consistent Signs Of Cardiac Remodeling And Reductions In Symptoms
Brief: Positive Interim Data From Cohorts 1 And 2 Of Tenaya's Ridge-1 Phase 1B/2 Clinical Trial Of TN-401
Tenaya Therapeutics Q1 net loss widens, misses analyst expectations
Brief: Tenaya Therapeutics Q1 Net Income USD -19.272 Million
Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027